セプシス誘発性肺損傷におけるlncRNA-miRNA-mRNAネットワークの解読:病原性から細胞外膀ベースの治療へ
Yating Wei1, Weiye Gong2, Yuhua Wei3
1Department of Emergency Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Frontiers in immunology
|February 13, 2026
まとめ
セプシス誘発性急性肺損傷 (S-ALI) は,複雑なRNAネットワークを伴う. これらのネットワークを細胞外小胞でターゲットにすることは,S-ALI治療の有望な治療戦略を提供します.
科学分野:
- 分子生物学は分子生物学である.
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
背景:
- セプシス誘発性急性肺損傷 (S-ALI) は,限られた治療法を持つ重症な状態です.
- 長い非コーディングRNA (lncRNA) -microRNA (miRNA) -mRNAの相互作用を含む,競合する内生RNA (ceRNA) ネットワークは,S-ALI.
- これらのネットワークは,アポトーシス,浸透性,免疫細胞活動などの重要な細胞プロセスを調節します.
研究 の 目的:
- S-ALI.におけるceRNAネットワークの理解における最近の進歩をレビューする.
- S-ALI治療のためのceRNAネットワークを標的とした治療の可能性を調査する.
主な方法:
- ceRNAネットワークとS-ALI.に関する最近の研究の文献レビュー.
- lncRNA-miRNA-mRNA軸がS-ALIの病原化にどのように影響するかを分析する.
- 細胞外膀ベースの治療戦略の評価.
主要な成果:
- ceRNAネットワークは,S-ALIにおけるアルベオラ上皮質アポトーシス,内皮質浸透性,マクロファージの極化,中性粒子の浸透を著しく調節する.
- これらの調節回路は,炎症,バリア機能障害,免疫機能不調を誘発する.
- エンジニアリングされた細胞外小胞は,ceRNA調節器の標的の配送の可能性を示しています.
結論:
- ceRNAネットワークは,S-ALI.の重要なレギュレーターです.
- ceRNAネットワークをターゲットにすること,特に細胞外ベジクルを使用することは,有望な治療の道を示しています.
- 翻訳性,冗長性,および配信効率に関する課題は,臨床適用のために対処する必要があります.
関連する概念動画
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs
3.7K
3.7K
Regulated mRNA Transport
7.1K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.1K
pre-mRNA Processing
57.6K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K
Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
The Extracellular Matrix
89.5K
Overview
89.5K


